Chronic Myelogenous Leukemia (CML)
Chronic Myelogenous Leukemia (CML) is a type of cancer that affects the bone marrow's capacity to produce red and white blood cells and platelets. CML is caused by a genetic mutation that leads to excessive production of white blood cells and is most common in adults over 55 years old. Symptoms may include easily bruising, frequent infections, fatigue, an enlarged spleen, and anemia. Although CML is treatable, patient outcomes vary by case. Treatment includes targeted therapy, chemotherapy and stem cell transplant. Early diagnosis and treatment of CML can help patients with a positive prognosis and improve their quality of life.
← Journal of Advances in Leukemia